History

Committed to transforming EEG.

We founded CortiCare as a tele-EEG diagnostic company with a simple premise: to help clinicians determine real-brain functionality and abnormality in a timely and cost-effective manner. Along the way, we've helped redefine neuro-critical care, expanded the use of in-home ambulatory EEG and provided support for clinical trials.


2012
CortiCare is awarded a portion of the NEOLEV2 drug dosage study awarded to UCSD to monitor up to 300 patients at 5 different hospitals over 3 years.
2013
CortiCare monitors its first patient with just a handful of technologists, and quickly expanded to 10 hospitals served.
2014
CortiCare grows to more than 30 technologists, averaging 10+ years of experience, many who have earned their CLTM.
2015
CortiCare hires its first team of neurophysiologists to provide expert reading services and retains its first contract for reading with a teaching hospital. CortiCare begins monitoring in its first EMU (Epilepsy Monitoring Unit).
2016
CortiCare partners with several well-known institutions, including UCLA and Emory, to provide EEG reading to multiple hospitals nationwide.
2017
CortiCare hires an EU manager and provides EEG monitoring to its first dog in the UK. CortiCare grows to nearly 40 technologists.
2018
CortiCare awarded a pilot program by the Minister of Health for Hospital Affairs in Saudi Arabia to demonstrate effectiveness of ICU brain monitoring services. As a result of this successful pilot, CortiCare is now in negotiations with one of the largest hospitals in Riyadh, Saudi Arabia to provide our real-time brain monitoring services.
2019
CortiCare expands its services to provide remotely monitored, in-home ambulatory video-EEG studies with the acquisition of Physician Ancillary Services with operations in of the US and a focus on providing the best service in the industry. CortiCare continues to grow its Pharma Clinical Trials services, working with sponsors or CROs to deliver safety EEG monitoring and interpretation.

Leadership

Management


BRAD WESTCOTT
President, CEO, Founder of CortiCare

Grew previous neuro-diagnostic company from $1M to over $30 million, including acquisitions both in US and abroad, and ending in a successful exit. He has served as CFO to another start-up in the medical space.

TIM INNES
VP Business Development

Former director of business development at Massimo, he has over 20 years of experience with medical device startups dealing with non- invasive patient monitoring technologies. He has put together strategic partnerships, technology transfers, sales, and marketing programs.

CARL TYLER
National Sales Manager

A founder of PAS, one of the largest companies offering in-home Ambulatory Video-EEG services, and a seasoned sales management professional, Carl oversees the US sales team. With a focus on serving the customer and providing the best

DR. DONA MURPHEY
Director of Scientific Affairs

Harvard Cum Laude undergrad. Baylor Ph.D. M.D. Dr. Murphey is a neurophysiologist with multidisciplinary training in brain disorder and development, and research articles on brain electrical signaling, mapping and stimulation.

DR. ERIC ANDERSON
Medical Director

Dr. Anderson obtained both his M.D. and Ph.D. at the University of Nebraska Medical Center. He completed his fellowship in clinical neurophysiology with a sub specialization in epilepsy at Emory University. He is widely licensed and credentialed and currently practices telemedicine in 25 states and over 80 hospitals.

DIANE LIESEN, R. EEG/EP T., CLTM
QA Manager

She also serves as the Program Director for the Neurodiagnostic Program at Lincoln Land College. She was the Clinical Coordinator and Staff Technologist for EEG programs at hospitals in both Colorado and Illinois. Past board member of both ASET and ABRET, including the executive committees.

STACI WESTCOTT
Director of Clinical Operations

Previous Operations Manager for Nuehealth, patient relationship SAAS connecting patients with providers. Previous customer service manager at Alpine Biomed, neuro-based diagnostic products.


Advisory Board


DR. MARC NUWER, MD

Corporate Board Member, Chief, Clinical Neurophysiology UCLA, Neurology Professor. Graduated from Stanford School of Medicine. Past Board Member American Academy of Neurology (AAN) and President of the Int’l Federation of Clinical Neurophysiology. He is considered an expert on Medicare reimbursement and CPT coding.

DR. BRAD KOLLS, MD, PhD

Vice Chair of Informatics and Teleradiology with the Duke’s Dept. of Neurology. Medical Director of Duke’s Tele-stroke Network. Clinical and translational research focusing on brain monitoring in acute brain injury. MCCi – Masters in Management and Clinical Informatics.

DR. JON HALFORD, MD

Director of Clinical Trials for the Dept. of Neurology at Medical University of South Carolina (MUSC). He is Associate Director for Technical Development at the MUSC Clinical Neurophysiology Lab, where he helped develop an EEG Cloud Platform. He is also the Director of the Consortium Site at the Charleston VA Epilepsy Centers of Excellence.

DR. RICHARD HAAS, MD, PhD

Dr. Haas is a pediatric Neurologist serving both Rady’s and UCSD. He serves on the editorial board of the European Journal of Pediatric Neurology. He is the Principle Investigator for the Neolev drug dosage study for neonates, for which CortiCare provides monitoring to the 6 hospitals involved.

DR. JEFFREY GERTSCH

Professor and Medical Director of Interventional Neurophysiology Lab UCSD. Department of Neurosciences. WSET Medical Director.